Khoan Vu

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Loretta J. Nastoupil, Michael D. Jain, Lei Feng et al. · Journal of Clinical Oncology · 2020 · 752 citations · Full text

Experience with Axicabtagene Ciloleucel (Axi-cel) in Patients with Secondary CNS Involvement: Results from the US Lymphoma CAR T Consortium

N. Nora Bennani, Matthew J. Maurer, Loretta J. Nastoupil et al. · Blood · 2019 · 59 citations

T Cell–Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia

Joan How, Michael Slade, Khoan Vu et al. · Biology of Blood and Marrow Transplantation · 2017 · 42 citations · Full text

Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis

Steven M. Bair, Lauren E. Strelec, Tatyana Feldman et al. · The Oncologist · 2018 · 40 citations · Full text

Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study

Khoan Vu, Chi-Heng Wu, Chen‐Yen Yang et al. · Clinical Cancer Research · 2019 · 38 citations · Full text